CellaVision AB (OTCPK:CLVSF)
$ 25.905 0 (0%) Market Cap: 476.81 Mil Enterprise Value: 467.45 Mil PE Ratio: 37.36 PB Ratio: 7.30 GF Score: 100/100

Q1 2021 CellaVision AB Earnings Call Transcript

Apr 28, 2021 / 09:00AM GMT
Release Date Price: $34.49
Operator

Ladies and gentlemen, welcome to CellaVision Q1 report for 2021. Today, I am pleased to present CEO, Simon Ãstergaard; and CFO, Magnus Blixt. (Operator Instructions) I will now hand over to Simon Ãstergaard. Please begin your meeting.

Simon Ã;stergaard;publ;CEO;President
CellaVision AB

()-&

Thank you very much. And good morning or good day, everybody, on the call. It's a pleasure, as CEO for CellaVision, to have the opportunity to present our Q1 interim report today.

It will be a 2-section presentation. So we'll first have a company presentation where I will elaborate on who we are, what we do and how and where we play. And this is the basis for the Q1 results that I'm happy to present. And then Magnus, I'm happy to hand the discussion in the Q&A session.

Next slide, please. And honestly, you can probably press twice. So the first slide, which will come up is about creating health care -- creating value in health care. So we're in the field of hematology. And our vision

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot